Life Tech's Decision to Discontinue SOLiD 3 Reagents Leaves Some Clinical Labs in the Lurch

While most SOLiD 3 users have already upgraded to the company's SOLiD 4 or 5500xl platforms, the decision surprised a few clinical labs with validated SOLiD 3 workflows who are now left with only a few months to upgrade their sequencers and revalidate their processes.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.